Tag Archives: Canaccord Genuity Corp

BlissCo Cannabis

Supreme Pharmaceuticals Announces $30 Million Bought Deal Private Placement of Convertible Debenture Units

Supreme Pharmaceuticals Announces $30 Million Bought Deal Private Placement of Convertible Debenture Units

TORONTO, Ontario, Oct. 17, 2017 /Weed Wire/ – Supreme Pharmaceuticals Inc. (the “Company”) (TSXV:FIRE) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, $30,000,000 aggregate principal amount of convertible debenture units (the “Convertible Debenture Units”) at a price of $1,000 per Convertible Debenture Unit.

Supreme Pharma

Supreme Pharmaceuticals Closes $55 Million Offering

TORONTO, Ontario, Dec. 13, 2016 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (CSE:SL) is pleased to announce the closing of its $50 million bought deal private placement (the “Brokered Offering”) and concurrent $5 million non-brokered private placement (together with the Brokered Offering, the “Offering”) for aggregate gross proceeds of $55 million.

Aurora Cannabis operational update

Aurora Announces Terms and Increase of Brokered Private Placement to $18 Million

VANCOUVER, British Columbia, July 18, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE: ACB) (OTCQB: ACBFF) is pleased to announce, further to its news release dated June 8, 2016, the pricing terms, and an increase in the size of its best efforts private placement offering of subscription receipts.


Top